Our Commitment to Patients

At BeOne Medicines, formerly known as BeiGene, “patients first” is more than a core value—it’s our guiding principle. Every day, we strive to create high-quality, innovative medicines faster for patients. It’s not enough for innovative drugs to simply exist. We want to make sure patients can access them. We work with cancer communities around the globe to learn from patients, their families and their care partners to help improve their lives by identifying and addressing their unmet needs.

In the UK & Ireland this means we can:

• Understand the most important clinical needs for patients living in the UK and Ireland.
• Have discussions with the National Institute for Health and Care Excellence (NICE), Scottish Medicines Consortium (SMC) and National Centre for Pharmacoeconomics (NCPE) that are informed by an understanding of patient needs and experiences. NICE, SMC and NCPE consider the clinical and economic impact of medicines, helping to provide patient access to the best treatments and care.
• Ensure our clinical trials teams design trials that best serve patients.
• Create materials that clearly explain clinical trials and help patients manage their disease.
• Collaborate on patient-focused initiatives such as patient support helplines.

Click here to see the patient groups we support in the UK and the patient resources we’ve developed in partnership with patient groups.